GlassScriptPhysician profile
Scott K Dhupar
NPI 1942289491
$60,471.59
in general payments reported to CMS, 2019-2025
12 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $21K · 2021: $12K · 2022: $4,009 · 2023: $1,791 · 2024: $996 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3,128 · Food and Beverage: $98.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,127.68 |
| Food and Beverage | $98.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $58,736.61 | 2019-2025 | Mojave Expandable Interbody System |
| Aegis Spine, INC. | $1,000.00 | 2020 | |
| Vb Spine LLC | $201.52 | 2025 | Mojave Expandable Interbody System |
| Orthofix Medical, INC. | $157.94 | 2019-2025 | Spinal-Stim |
| Spinal Elements, INC. | $129.82 | 2019-2020 | |
| Surgalign Spine Technologies, INC. | $114.56 | 2020 | |
| Medtronic USA, INC. | $31.84 | 2019 | |
| Si-Bone, INC. | $31.28 | 2025 | |
| Hologic Sales and Service, LLC | $28.58 | 2022 | |
| Lemaitre Vascular, INC. | $23.45 | 2020 | |
| Misonix INC | $15.99 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Dhupar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.